Glenn Goddard has sold NTLA and made no open-market buys since Aug 2021
EVP and CFO at Intellia Therapeutics, Inc.
SEC CIK 0001581992 · Filings on SEC.gov ↗
$0Bought
$8.8MSold
NoneLast buy
Every filing
6 filings since Aug 2021, newest first
NTLASell
Intellia Therapeutics, Inc.
EVP and CFO
$158K−12.0%Jan 5
NTLASell
Intellia Therapeutics, Inc.
EVP and CFO
$90K−14.0%Jan 6
NTLASell
Intellia Therapeutics, Inc.
EVP and CFO
$114K−6.0%Mar 3
NTLASell
Intellia Therapeutics, Inc.
EVP and CFO
$627K−100.0%Sep 9
NTLASell
Intellia Therapeutics, Inc.
EVP and CFO
$4.8M−100.0%Sep 1
NTLASell
Intellia Therapeutics, Inc.
EVP and CFO
$3.0M−100.0%Aug 6
Filings come from SEC EDGAR. Not investment advice.